Shona Macrae

Cambridge, ENG CB20XZ, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activity.

Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activity.

Journal: Nature communications
Published: July 15, 2021

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.

Journal: International journal of cancer
Published: December 27, 2018

Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma.

Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma.

Journal: Nature genetics
Published: October 21, 2018

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.

Journal: Gut
Published: September 19, 2018

The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic.

The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic.

Journal: Nature genetics
Published: April 27, 2018

Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus.

Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus.

Journal: Gastroenterology
Published: March 11, 2018

Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics.

Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics.

Journal: Nature communications
Published: December 14, 2017

Corrigendum: A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.

Corrigendum: A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.

Journal: Genome research
Published: October 05, 2017

Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.

Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.

Journal: Gut
Published: February 22, 2017

Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Journal: Nature genetics
Published: February 01, 2017

A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.

A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.

Journal: Genome research
Published: August 23, 2016

Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study.

Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study.

Journal: The lancet. Gastroenterology & hepatology
Published: August 19, 2016
Showing 1-12 of 17

Last Updated: 09/26/2026